Has Adham Jurdi received payments from drug or device companies?

Yes. Drug and device makers reported $41,396 in general payments to Adham Jurdi across 227 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adham Jurdi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adham Jurdi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adham Jurdi

Medical Oncology · Austin, TXNPI 1447414776

Payments from drug & device makers

$41,396in general payments, 2019–2025

Across 227 payments — averaging $182.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$16K
Astellas Pharma US Inc$7K
Acerta Pharma LLC$7K
Foundation Medicine, Inc.$6K
Array Biopharma Inc$2K
Johnson & Johnson$481
plus $3K from 42 others

$239in research payments, 2019–2025

Across 1 payment — averaging $238.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

F. Hoffmann-la Roche AG$239

What the payments were for

Consulting fees$8,65847%
Speaking & faculty fees$1,7009%
Travel & lodging$3,84321%
Food & beverage$4,13522%
Education$1181%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	6	$16,403
Astellas Pharma US Inc	6	$6,699
Acerta Pharma LLC	1	$6,538
Foundation Medicine, Inc.	14	$6,329
Array Biopharma Inc	2	$1,716
Johnson & Johnson	25	$481
E.r. Squibb & Sons, L.L.C.	19	$331
Sanofi	18	$295
Merck	13	$235
Bristol Myers Squibb	12	$209
Novartis	10	$194
AstraZeneca(2 entities)	10	$183
Seagen Inc.	8	$152
Incyte Corporation	8	$144
Eisai Inc.	8	$133
Lilly USA, LLC	7	$123
Pfizer	7	$101
Pharmacyclics LLC, An Abbvie Company	5	$100
Covidien LP	1	$96
Integra Lifesciences Corporation	1	$95
Karyopharm Therapeutics Inc.	3	$72
Taiho Oncology, Inc.	4	$61
Beigene USA, Inc.	3	$54
Daiichi Sankyo Inc.	2	$42
Puma Biotechnology, Inc.	2	$40
Davol Inc.	1	$39
Ipsen Biopharmaceuticals, Inc	2	$39
Takeda Pharmaceuticals U.S.A., Inc.	2	$34
Amgen	2	$32
AbbVie	2	$32
Genentech USA, Inc.	2	$30
Exelixis Inc.	2	$28
Pharmacosmos Therapeutics Inc.	2	$28
Gilead	2	$27
Myriad Genetic Laboratories, Inc.	2	$26
Teva Pharmaceuticals USA, Inc.	1	$22
Secura Bio, Inc.	1	$22
Sanofi-aventis U.S. LLC	1	$22
Regeneron Healthcare Solutions, Inc.	1	$21
Kyowa Kirin, Inc.	1	$21
Lexicon Pharmaceuticals, Inc.	1	$20
Epizyme, Inc.	1	$19
Rigel Pharmaceuticals, Inc.	1	$19
Myovant Sciences Inc.	1	$19
Immunomedics, Inc.	1	$18
Alnylam Pharmaceuticals Inc.	1	$17
EMD Serono, Inc.	1	$16
Morphosys, US Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,396 in reported general payments places this provider in the 50th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas →

Other medical oncology in Austin

Jason MelearAustin$14.1M
Hagop KantarjianHouston$100.5M
Timothy YapHouston$56.7M
Yasir ElaminHouston$41.3M
David HongHouston$31.6M
Guillermo Garcia-ManeroHouston$31.6M
Jason WestinHouston$30.8M
Sawsan RashdanDallas$29.9M
Lucia MasarovaHouston$29.7M
Jordi Rodon AhnertHouston$28.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →